Tag - health

 
Menu
Search
 
November 07, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

HEALTH

Japan Times
COMMENTARY / Japan
Nov 18, 2020
Can Japan bridge the vaccine divide?
Japan too has been developing its own drug, Avigan, against COVID-19. Yet the drug being developed by Fujifilm is not a vaccine but rather a treatment for coronavirus symptoms.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Politics
Nov 18, 2020
Biden names top White House aides as doctors urge Trump to cooperate on COVID-19
President-elect Joe Biden on Tuesday named several senior staffers for his White House, while his top coronavirus advisers warned that President Donald Trump's stalling of the official transition could compromise the country's pandemic response.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
COMMENTARY / World
Nov 16, 2020
A vaccine won't derail the easy money train
Don't get carried away by the good news on vaccine development. Central banks are miles from the exit ramp for the tremendous stimulus they've pumped into the economy.
Japan Times
WORLD
Nov 16, 2020
U.S. doctors are calling it quits under stress of the pandemic
Thousands of medical practices have closed during the pandemic, according to a July survey of 3,500 doctors by the Physicians Foundation, a nonprofit group.
Japan Times
COMMENTARY / World
Nov 15, 2020
Here’s to the immigrant heroes behind the BioNTech vaccine
Their journey as Turkish Germans cannot have been easy. Discrimination, overt or subtle, is rife in German society.
Japan Times
WORLD / Science & Health
Nov 14, 2020
Britain to pilot COVID-19 tests for care home visitors
Visitors to care homes in parts of England will be able to get tested for COVID-19 under a new pilot plan aimed at reducing onerous restrictions in time for Christmas, the health ministry said Saturday.
JAPAN / Society
Nov 13, 2020
Japan faces another coronavirus wave, but this one’s different
A high number of asymptomatic cases compared to previous outbreaks, as well as more transmissions in households and workplaces, are forcing a rethink.
Japan Times
COMMENTARY / World
Nov 13, 2020
What happens to the other COVID-19 vaccines now?
If the vaccine created by Pfizer and partner BioNTech fails to live up to its promise, will any slower but better competitors have a chance?
Japan Times
WORLD / Science & Health
Nov 12, 2020
Moderna COVID-19 vaccine trial reaches key goal to gauge merit
The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
WORLD / FOCUS
Nov 12, 2020
The surging coronavirus finds a U.S. leadership vacuum
As the United States enters what may be the most intense stage of the pandemic yet, the Trump administration remains largely disengaged.
JAPAN / Society
Nov 11, 2020
Japan's surge in COVID-19 cases reignites debate over tougher virus law
Experts say changes are an immediate necessity and could be achieved within months if not for complacency and bipartisan politics.
Japan Times
WORLD
Nov 11, 2020
Brazil halts trial of Chinese vaccine. But was science or politics to blame?
Brazil's health regulator provided little information on its decision to suspend the trial, including whether a reported adverse reaction was related to the vaccine.
Japan Times
WORLD / Science & Health
Nov 10, 2020
Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle
The vaccine candidate is more than 90% effective based on initial trial results, the drugmaker said Monday.
Japan Times
WORLD / Politics
Nov 7, 2020
Americans lost 138 million hours of sleep on election night
In the U.S., election night was the low point of the year when it comes to sleep.
Japan Times
COMMENTARY / World
Nov 7, 2020
The potential for a policy failure on vaccines is huge
Leaders must make decisions about who will get a coronavirus shot first and provide adequate explanations to those denied the vaccine.
The Toyota buyout is a major test for Japan’s reforms
Akio Toyoda, chairman of Toyota Motor, speaks during a media preview at the Japan Mobility Show in Tokyo on Oct. 29. Minority investors are challenging the carmaker's bid to take affiliate Toyota Industries Corp. private.
From France to Mali, a deportee's struggle far from home
Moussa Sacko, a Malian deported from France — where he had lived since he was a young child — stands on a street in Bamako, Mali, in December. Compared with his home in France, Bamako feels like a different planet, Sacko said.
ChatGPT nickname and Trump tariffs nominated for Japan’s buzzword of 2025
Women hold toys depicting Myaku-Myaku, the official character for the 2025 Osaka Expo, during a media day ahead of the event's public opening day in Osaka in April.
SoftBank is said to have explored potential takeover of Marvell
SoftBank explored a potential takeover of U.S. chipmaker Marvell Technology earlier this year, in what would have been the semiconductor industry's largest-ever deal.
The second life of Japan's net cafes
Once smoky, male-dominated spaces, today's net cafes, like Kaikatsu Club, are working to make their operations more attractive to women customers.
Across borders and screens, Tokyo film festival finds humanity in migration
“Mother Bhumi” takes place in a multiethnic rice-farming community where Chinese, Thai and Malay lineages intertwine.
Takaichi’s balancing act: Supporting Taiwan and stabilizing China ties
Prime Minister Sanae Takaichi shakes hands with Lin Hsin-i, Taiwan’s presidential adviser, on the sidelines of an Asia-Pacific Economic Cooperation summit meeting in Gyeongju, South Korea, on Saturday in this image posted to Takaichi's official X account.
From 1973 to 2025: A Japanese American skater’s long ride to recognition
Judi Oyama at Winchester Skatepark in San Jose, California, in January 1979. The Skateboarding Hall of Fame inductee and Guinness World Record holder still skates and hopes to inspire older women.
More Japanese universities pushing toward teaching in English
Waseda University in Tokyo
Young Indonesians in Japan find their political voice
Indonesian students at Hiroshima University hold posters of the 17+8 Demands, demanding transparency and action from their homeland’s government.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Once smoky, male-dominated spaces, today's net cafes, like Kaikatsu Club, are working to make their operations more attractive to women customers.
The second life of Japan's net cafes
By Alex K.T. Martin

SUSTAINABLE JAPAN

Maruhachi never sleeps in quest for better futons
Maruhachi never sleeps in quest for better futons

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER